
Kirjaudu sisään Inderes Free -tilillesi nähdäksesi kaikki sivun maksuton sisältö.
ADDvise Group
1,324
SEK
+4,58 %
Alle 1K seuraajaa
ADDV B
First North Stockholm
Medical Equipment & Services
Health Care
Yleiskuva
Omistajat
Sijoittajakonsensus
+4,58%
+8,35%
−28,56%
−43,53%
−62,41%
−76,23%
−71,85%
+83,85%
−36,58%
ADDvise Group offers complete solutions for healthcare and research units, which include laboratory equipment, protective ventilation, and various consumables. The business is managed based on two business segments: Lab and Healthcare. The customers are found mainly in the Nordic market, but also in the rest of the international market and include both customers in the private and public sectors. The company is headquartered in Stockholm.
Lue lisääMarkkina-arvo
802,43 milj. SEK
Vaihto
1,5 milj. SEK
Liikevaihto
EBIT %
P/E -luku
Osinkotuotto %
Pörssikalenteri
6.5.
2025
Yhtiökokous '25
9.5.
2025
Osavuosikatsaus Q1'25
17.7.
2025
Osavuosikatsaus Q2'25
Kaikki
Webcastit
Tiedotteet
NäytäKaikki sisältötyypit

Notice to the annual general meeting of ADDvise Group AB (publ)
ADDvise Group AB: ADDvise raises approximately SEK 457 million in the rights issue
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
FREE-tili
Pörssin suosituin aamukatsaus
Analyytikon kommentit ja suositukset
Osakevertailu
PREMIUM-tili
Kaikki yhtiöraportit ja sisällöt
Premium-työkalut (mm. sisäpiirin kaupat ja screeneri)
Mallisalkku
ADDvise Group AB: ADDvise Group publishes annual report and sustainability report for 2024
ADDvise Group AB: ADDvise announces preliminary outcome of the rights issue
ADDvise Group AB: ADDvise publishes prospectus in connection with a rights issue
Report from the extra ordinary general meeting in ADDvise Group AB (publ)

ADDvise Group, Audiocast with teleconference, Q4'24
ADDvise Group AB: Year-end report 2024, January 1-December 31
Notice to extraordinary general meeting of ADDvise Group AB (publ)
ADDvise Group AB: The Board of Directors of ADDvise has resolved on a rights issue of SEK 457 million
ADDvise Group AB: ADDvise presents preliminary financial information for the fourth quarter of 2024 and updates long-term financial targets
ADDvise Group AB: Invitation to presentation of interim report October 1 - December 31, 2024
ADDvise Group AB: ADDvise receives order worth EUR 2.6 million
ADDvise Group AB: ADDvise receives allocation decision worth approximately SEK 72 million
ADDvise Group AB: ADDvise explores potential divestment of its subsidiary Germa
ADDvise Group AB: ADDvise receives order worth USD 1.8 million
ADDvise Group AB: ADDvise streamlines organization through new business area structure
Redeye: ADDvise Q3 2024 - Comparables set to ease from Q4 2024e
